ArticleScientific reports2026
Mast cell-driven remodeling of pulmonary immune and stromal landscapes in COVID-19.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
The role of mast cells (MCs) in the pathogenesis of COVID-19 remains poorly understood. In the present study, we profiled the spatial phenotype of MC interaction with the pulmonary immune and stromal landscapes. The study included lung tissue samples from 12 COVID-19 patients and 12 patients with undifferentiated community-acquired pneumonia (CAP). Histochemical, monoplex, and multiplex immunohistochemical staining with spatial phenotyping, profiling, and mapping of MCs, as well as interactions with the immune and stromal landscape of the lungs, including elastic and collagen fibers, were used. Compared with other respiratory infections, SARS-CoV-2-associated pneumonia caused an increase in the pool of MCs in the lungs simultaneously with the activation of targeted secretion of tryptase and the formation of significant differences in the spatial phenotype of colocalization of MCs with immunocompetent cells and fibers. The intensity of juxtacrine and paracrine interactions of MC with cytotoxic lymphocytes and monocytes increased, initiating the polarization of macrophages into type 2. In this case, MCs and type 2 macrophages formed extended multicellular chains in the form of a functional syncytium, creating profibrotic niches of the local tissue microenvironment. Under COVID-19 conditions, an unexpected increase in MC interaction with elastic extracellular matrix (ECM) fibers and localized tryptase release revealed new insights into tissue tensometry and ECM remodeling. New spatial patterns of interaction between MCs and the immune and stromal landscape may have beneficial effects in developing therapeutic solutions for fibrotic change prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.